EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Microfluidics Lab‐on‐a‐Chip Approaches to Decipher Atherosclerosis Pathogenesis

Fahima Akther, Hang Thu Ta iD

Small · 09.11.2026

DOI: 10.1002/smll.202512063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 09.11.2026. Verfasst von Fahima Akther und 1 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, Queensland, Australia. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ARC Future Fellowship, Heart Foundation Future Leader Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a complex, multifactorial disease driven by intricate cellular and molecular interactions within the vascular microenvironment. While conventional experimental models have provided important insights into disease progression, they often fail to recapitulate the coupled mechanical and biochemical stimuli that govern vascular pathology in vivo. Lab‐on‐a‐chip technologies offer a powerful platform for reconstructing key cellular and tissue‐level features of atherosclerosis within controlled microscale environments, enabling the study of processes such as endothelial dysfunction, inflammatory signaling, cell‐matrix interactions, and vascular remodeling. The integration of microfluidics further enhances these models by enabling precise control of flow‐derived mechanical cues, including shear stress, vascular geometry, and pulsatile pressure. This review highlights recent advances in microfluidic lab‐on‐a‐chip models for atherosclerosis research, with a focus on their ability to replicate human‐relevant pathophysiological conditions. We discuss pioneering studies that have employed these paltforms to investigate endothelial barrier dysfunction, monocyte recruitment, foam cell formation, vascular remodeling, and plaque instability across different stages of disease progression. Collectively, these microfluidic systems provide powerful, physiologically relevant tools for dissecting the mechanisms underlying atherosclerosis and evaluating therapeutic strategies under controlled, biomimetic vascular conditions.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosisin vitromicrofluidicorgan‐on‐a‐chippathogenicity

Autor:innen und Institutionen

  • Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, Queensland, Australia.
  • Queensland Quantum and Advanced Technologies Research Institute (QUATRI), Nathan Campus, Griffith University, Brisbane, Queensland, Australia.
  • Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.
  • School of Environment and Science, Griffith University, Nathan, Queensland, Australia.

ORCID-Profile: Hang Thu Ta

Förderung

  • ARC Future Fellowship
  • Heart Foundation Future Leader Fellowship

Zitieren

APA

Akther, F., & Ta, H. T. (2026). Microfluidics Lab‐on‐a‐Chip Approaches to Decipher Atherosclerosis Pathogenesis. Small. https://doi.org/10.1002/smll.202512063

Vancouver

Akther F, Ta HT. Microfluidics Lab‐on‐a‐Chip Approaches to Decipher Atherosclerosis Pathogenesis. Small. 2026. doi:10.1002/smll.202512063

BibTeX
@article{Akther2026,
  author = {Akther, Fahima and Ta, Hang Thu},
  title = {Microfluidics Lab‐on‐a‐Chip Approaches to Decipher Atherosclerosis Pathogenesis},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202512063}
}
Kostenlos starten →